Johan Lundin

11.0k citations

160 papers · 7.5k indexed · 1 hit paper · h-index 48

Impact in

Health Informatics top 1%
Cancer Research top 1%
- Breast Cancer Treatment Studies

Papers in

Health Informatics 5
Biophysics 17
- Cell Image Analysis Techniques 17

Co-authors: Mikael Lundin Heikki Joensuu Caj Haglund Jorma Isola Stig Nordling Nina Linder Ari Ristimäki Riku Turkki
Journals: Oncology (12 papers)Diagnostic Pathology (8 papers)British Journal of Cancer (8 papers)Scientific Reports (6 papers)International Journal of Cancer (6 papers)
Partner nations: Finland Sweden United States

In The Last Decade

Johan Lundin

154 papers receiving 7.3k citations

Hit Papers

align trajectories log scale

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. 2002 · 672 citations

Peers

Countries citing papers authored by Johan Lundin

Since Specialization

Citations

This map shows the geographic impact of Johan Lundin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Lundin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Lundin more than expected).

Fields of papers citing papers by Johan Lundin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Lundin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Lundin. The network helps show where Johan Lundin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Johan Lundin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Johan Lundin Line = papers co-authored together Johan Lundin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	AI-supported versus manual microscopy of Kato-Katz smears for diagnosis of soil-transmitted helminth infections in a primary healthcare setting Scientific Reports ·Felipe José Mesch, A. Nayerhoda, 毛晖圆, E T Richard Dean, Hideo Andoh, Akylbek Kabzhanov, Jessica Chaffkin, I. Bekkaye, Melih Çattık, Billy Ngasala, Mikael Lundin, Andreas Mårtensson, Nina Linder, Johan Lundin	2025	0
2	AI-Supported Digital Microscopy Diagnostics in Primary Health Care Laboratories: Protocol for a Scoping Review JMIR Research Protocols ·Felipe José Mesch, Vinod Diwan, Andreas Mårtensson, Nina Linder, Johan Lundin	2024	2
3	Diagnosis of soil-transmitted helminth infections with digital mobile microscopy and artificial intelligence in a resource-limited setting PLoS neglected tropical diseases ·Johan Lundin, A. Nayerhoda, Ronald O. Baird, Clive N. Bennett, Peng Zhang, E T Richard Dean, Hideo Andoh, Akylbek Kabzhanov, Mikael Lundin, Vinod Diwan, Andreas Mårtensson, Nina Linder	2024	9
4	Development and evaluation of deep learning algorithms for assessment of acute burns and the need for surgery Scientific Reports ·D. Y. Kim, Lucie Laflamme, 照子二宮, Mikael Lundin, 渡部笑麗, Lee Wallis, Nikki Allorto, Johan Lundin	2023	9
5	Machine-learning–driven biomarker discovery for the discrimination between allergic and irritant contact dermatitis Proceedings of the National Academy of Sciences ·Vittorio Fortino, Lukas Wisgrill, Н. Голікова, Sari Suomela, Nina Linder, Erja Jalonen, Alina Suomalainen, Veer Singh Marwah, Mia Kero, Maria Pesonen, Johan Lundin, Antti Lauerma, Kristiina Aalto‐Korte, Dario Greco, Harri Alenius, Nanna Fyhrquist	2020	54
6	Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours Journal of Clinical Pathology ·Nina Linder, Jenny C. Taylor, Richard Colling, 武雅璐, Edward Alveyn, Johnson Joseph, Andrew Protheroe, Mikael Lundin, Johan Lundin, Clare Verrill	2018	53
7	Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient‐derived cancer cells International Journal of Cancer ·Khalid Saeed, Dongsu Choi, Teijo Pellinen, Samuli Eldfors, Riku Turkki, Johan Lundin, Petrus Järvinen, Harry Nísen, Kimmo Taari, Taija M. af Hällström, Antti Rannikko, Tuomas Mirtti, Olli Kallioniemi, Päivi Östling	2018	26
8	An Extensive Tumor Array Analysis Supports Tumor Suppressive Role for Nucleophosmin in Breast Cancer American Journal Of Pathology ·Aulya Fazira, Antti Rivinoja, Johan Lundin, Maija Hyvönen, E.H. Hopman, Joshua Cable, Harri Sihto, Mikael Lundin, Päivi Heikkilä, Heikki Joensuu, Petri Bono, Pirjo Laakkonen	2011	27
9	Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study Breast Cancer Research ·Harri Sihto, Johan Lundin, Mikael Lundin, Terho Lehtimäki, Ari Ristimäki, Kaija Holli, Liisa Sailas, Vesa Kataja, Taina Turpeenniemi‐Hujanen, Jorma Isola, Päivi Heikkilä, Heikki Joensuu	2011	181
10	Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer The EMBO Journal ·Biswajyoti Sahu, Marko Laakso, Kristian Ovaska, Tuomas Mirtti, Johan Lundin, Antti Rannikko, Anna Sankila, Saeid Moosavi, Mikael Lundin, Juho Konsti, Tiina Vesterinen, Stig Nordling, Olli Kallioniemi, Sampsa Hautaniemi, Olli A. Jänne	2011	296
11	High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer British Journal of Cancer ·Camilla Böckelman, Jaana Hagström, Laura K. Mäkinen, Harri Keski–Säntti, Valtteri Häyry, Johan Lundin, Timo Atula, Ari Ristimäki, Caj Haglund	2011	49
12	Association of Wwox with ErbB4 in Breast Cancer Cancer Research ·Rami I. Aqeilan, Valentina Donati, Eugenio Gaudio, Milena S. Nicoloso, Maria Sundvall, Anna Korhonen, Johan Lundin, Jorma Isola, Marius Sudol, Heikki Joensuu, Carlo M. Croce, Klaus Elenius	2007	95
13	Cleavable ErbB4 Isoform in Estrogen Receptor–Regulated Growth of Breast Cancer Cells Cancer Research ·Teemu T. Junttila, Maria Sundvall, Mikael Lundin, Johan Lundin, Minna Tanner, Pirkko Härkönen, Heikki Joensuu, Jorma Isola, Klaus Elenius	2005	159
14	Web-based virtual microscopy in teaching and standardizing Gleason grading☆ Human Pathology ·H Helin, Mikael Lundin, Johan Lundin, Paula Martikainen, Teuvo L.J. Tammela, Heikki Helin, Theodorus van der Kwast, Jorma Isola	2005	74
15	High tissue expression of tumour‐associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer Histopathology ·NANDA, Johan Lundin, Stig Nordling, Arto Kokkola, Ulf‐Håkan Stenman, Caj Haglund	2005	30
16	Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study. PubMed ·Heikki Joensuu, Jorma Isola, Mikael Lundin, Tiina Salminen, Kaija Holli, Vesa Kataja, Liisa Pylkkänen, Taina Turpeenniemi‐Hujanen, Karl von Smitten, Johan Lundin	2003	161
17	Predicting fatal outcome in the early phase of severe acute pancreatitis by using novel prognostic models Pancreatology ·Kimmo I. Halonen, Ari Leppäniemi, Johan Lundin, Pauli Puolakkainen, Esko Kemppainen, Reijo Haapiainen	2003	55
18	Sialyl Tn Is a Frequently Expressed Antigen in Colorectal Cancer: No Correlation with Patient Prognosis Oncology ·Johan Lundin, Stig Nordling, Peter Roberts‎, Monika Carpelan‐Holmström, Kristina von Boguslawsky, Caj Haglund	1999	15
19	Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer British Journal of Cancer ·Monika Carpelan‐Holmström, Caj Haglund, Johan Lundin, Henrik Alfthan, Ulf‐Håkan Stenman, Yisen Gao	1996	45
20	The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer British Journal of Cancer ·Johan Lundin, PJ Roberts, Pentti Kuusela, Caj Haglund	1994	96

About Johan Lundin

Johan Lundin is a scholar working on Health Informatics, Biophysics, Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 160 papers that have together received 7.5k indexed citations. Recurring topics across this work include AI in cancer detection (35 papers), Radiomics and Machine Learning in Medical Imaging (22 papers), Cell Image Analysis Techniques (17 papers), Breast Cancer Treatment Studies (16 papers), Glycosylation and Glycoproteins Research (12 papers), Cancer Genomics and Diagnostics (11 papers), HER2/EGFR in Cancer Research (11 papers) and Cancer-related Molecular Pathways (9 papers). The work is most often cited by research in Health Informatics (142 citations), Cancer Research (1.6k citations), Oncology (2.8k citations), Biophysics (297 citations) and Radiology, Nuclear Medicine and Imaging (1.2k citations). Johan Lundin has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Mikael Lundin, Heikki Joensuu, Caj Haglund, Jorma Isola, Stig Nordling, Nina Linder, Ari Ristimäki, Riku Turkki, Tiina Salminen and Caj Haglund. Their work appears in journals such as Oncology, Diagnostic Pathology, British Journal of Cancer, Scientific Reports and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact